Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
Collet Clinical and Research from Pajottegem, company number BE0743459171, closed financial year 2025 with a result of € 72,000 after tax. For that financial year Collet Clinical and Research recorded a gross margin of € 108,144 and equity of € 183,556. Compared with financial year 2024, the result moved from € 91,001 to € 72,000. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.
€ 183,556
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 72,000
▼ 21% vs 2024
Profit after tax over the fiscal year.
€ 89,707
▲ 76% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 72,000 paid out
100 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 31,546
▼ 37% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 23,350
▼ 55% vs 2024
Loans from banks and other lenders, long and short.
€ 430
▼ 2% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 25,525
▼ 28% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 291,252 | € 209,318 | € 147,169 | € 108,144 | ▼ 27% |
| Profit after taxes | € 217,517 | € 143,723 | € 91,001 | € 72,000 | ▼ 21% |
| Equity | € 182,832 | € 183,555 | € 183,556 | € 183,556 | |
| Total debts | € 435,138 | € 342,302 | € 164,581 | € 55,951 | ▼ 66% |
| Cash | € 67,903 | € 33,150 | € 50,899 | € 89,707 | ▲ 76% |
| Retained profit | € 176,832 | € 177,555 | € 177,556 | € 177,556 | |
| Dividend | € 217,000 | € 143,000 | € 91,000 | € 72,000 | ▼ 21% |
| Bank debt | € 93,680 | € 129,731 | € 52,390 | € 23,350 | ▼ 55% |
| Balance sheet total | € 617,970 | € 525,857 | € 348,137 | € 239,508 | ▼ 31% |
Key figures of Collet Clinical and Research, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Collet Clinical and Research?
What happened at Collet Clinical and Research in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 72,000 (▼ 21% vs 2024). filed late Source: NBB ↗
- New establishment in Aalst. KBO
- Start of the company according to the CBE. KBO
In short
From € 217,517 profit in 2022 to € 72,000 profit in 2025.
Paid € 159,943 in corporate taxes since 2022.
Best year ever: 2022, with € 217,517 profit.
Paid out € 523,000 in dividends to the owners in total.
Management
Behind Collet Clinical and Research is Carlos Collet Bortone. Carlos Collet Bortone is also behind MXMDD.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Hekstraat(HN) 28
1540 Pajottegem
Moorselbaan 164
9300 Aalst
Active since 10 February 2020
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0743.459.171
- VAT number
- BE 0743.459.171
- Registered office
- Hekstraat(HN) 28, 1540 Pajottegem
- Names & denominations
- Collet Clinical and Research
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 February 2020
- Peppol
- Not registered
- Activities · NACE
Activiteiten van medisch specialisten